A diabetes, heart failure and kidney disease medication (sotagliflozin) is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and…
Exercise improves brain function, possibly reducing dementia risk
A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how the body responds to insulin are activated in the brain after exercise, suggesting…
Bird flu during pregnancy: women died in 90% of cases
The vast majority of women who contract bird flu during pregnancy and their unborn baby will die from the virus, according to a new study. And the findings stress the…
BRCA, JOLIE E BALTI? NON C’E’ REGOLA CHE VALE PER TUTTE
La storia medica del Brca (la mutazione Jolie) non è solo medica. A voler raccontare bene delle donne che scoprono di avere una mutazione patogenetica che espone al rischio di…
‘Digital twins’ of real cancer patients with algorithms to discover black holes
Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The technology, called FarrSight®-Twin, which is based on algorithms used…
An AI-powered pipeline for personalized cancer vaccines
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses…
UNA NUOVA ERA PER L’ ONCOEMATOLOGIA PEDIATRICA. CONGRESSO NAZIONALE AIEOP
Da lunedì prossimo, 30 settembre, a mercoledì 2 ottobre l’Hotel Savoia Regency di Bologna diventa il palcoscenico del XLIX Congresso Nazionale di AIEOP (Associazione Italiana Ematologia e Oncologia Pediatrica), un…
Evening vs. morning dosing of blood pressure medication: no differences seen #ESCCongress #ESC24 #ESC2024
In two trials, one in frail elderly patients, evening administration of blood pressure (BP)-lowering medications had no clinical benefits over morning administration, according to late-breaking research presented in a Hot…
The antiviral tecovirimat is safe but did not improve Clade I #mpox resolution in Democratic Republic of the Congo DRC
The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on…
Immunotherapy approach shows potential in some people with metastatic solid tumors
Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National…